When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

MALT lymphoma

Last reviewed: 12 Dec 2025
Last updated: 10 Jan 2025

Summary

Definition

History and exam

Key diagnostic factors

  • history of Helicobacter pylori gastritis
  • history of autoimmune disorder
  • age >60 years
  • dyspepsia
  • epigastric discomfort
  • skin lesions
  • red eye ± photophobia
  • conjunctival fornix mass
  • painless proptosis, motility disturbances of the eye, diplopia, ptosis, decreased vision
Full details

Other diagnostic factors

  • abdominal pain, nausea, diarrhea, malabsorption, vomiting
  • GI bleeding, perforation, and obstruction
  • fever
  • night sweats
  • weight loss
  • shortness of breath, hemoptysis, cough
  • salivary gland swelling
  • thyroid swelling
  • esophageal/tracheal obstruction (shortness of breath, dysphagia, tracheal deviation)
  • breast lump
  • focal neurologic deficits
  • lymphadenopathy
Full details

Risk factors

  • Helicobacter pylori infection
  • age >60 years
  • autoimmune disease
  • Chlamydia psittaci infection
  • Campylobacter jejuni infection
  • Borrelia burgdorferi infection
  • hepatitis C virus infection
  • hepatitis B virus infection
  • HIV infection
  • achromobacter xylosoxidans infection
Full details

Diagnostic tests

1st tests to order

  • CBC with differential
  • blood smear
  • comprehensive metabolic panel (including LFTs)
  • serum lactate dehydrogenase (LDH)
  • serum beta-2 microglobulin
  • upper GI endoscopy
  • biopsy of affected site
  • immunophenotyping
  • H pylori (histologic testing)
  • CT scan
Todos los datos

Pruebas diagnósticas que deben considerarse

  • H pylori (stool antigen test)
  • H pylori (urea breath test)
  • H pylori (serology test)
  • PCR testing for infectious agents
  • bone marrow biopsy with aspirate
  • genetic studies
  • immunoglobulin gene rearrangement studies
  • MYD88 mutation testing
  • serum protein electrophoresis
  • 18F-fluorodeoxyglucose (FDG) PET/CT scan
  • endoscopic ultrasound of the stomach
  • lower GI endoscopy
  • MRI orbit, brain
  • mammography
  • breast ultrasound
  • MRI breast
  • thyroid ultrasound
  • bronchoscopy
  • hepatitis C serology
  • hepatitis B serology
  • HIV serology
  • multigated acquisition (MUGA) scan
  • echocardiography
Todos los datos

Algoritmo de tratamiento

Agudo

localized gastric MALT lymphoma: Helicobacter pylori-positive and t(11;18)-negative (or unknown)

localized gastric MALT lymphoma: Helicobacter pylori-negative, or Helicobacter pylori-positive and t(11;18)-positive

advanced gastric MALT lymphoma

localized nongastric MALT lymphoma

advanced nongastric MALT lymphoma

high-grade histologic transformation

Colaboradores

Autores

Christopher McNamara, MBBS (Hons), FRACP, FRCPA, FRCPath

Consultant Haematologist

Royal Free Hospital

London

UK

Divulgaciones

CM declares that he has no competing interests.

Agradecimientos

Dr Christopher McNamara wishes to gratefully acknowledge Dr Rahul Joshi, a previous contributor to this topic. RJ declared that he had no competing interests. Unfortunately, we have since been made aware that Dr Rahul Joshi is deceased.

Revisores por pares

Markus Raderer, MD

Professor of Medicine

Department of Internal Medicine I

Division of Oncology

Medical University Vienna

Austria

Divulgaciones

MR is an author of a number of references cited in this topic.

Alan Lichtin, MD

Staff Hematologist

Cleveland Clinic Taussig Cancer Center

Cleveland

OH

Divulgaciones

AL declares that he has no competing interests.

Ian Chau, MD

Consultant Medical Oncologist

Royal Marsden Hospital

Sutton

UK

Divulgaciones

IC has been reimbursed by Roche Products, the manufacturer of rituximab, for attending several conferences. IC has also served on advisory boards and received honorarium for giving presentations for Roche Products. IC has received research funding from Novartis to conduct academic studies in the treatment of colorectal cancer.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Zucca E, Arcaini L, Buske C, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Jan;31(1):17-29.Texto completo  Resumen

Walewska R, Eyre TA, Barrington S, et al. Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology guideline. Br J Haematol. 2024 Jan;204(1):86-107.Texto completo  Resumen

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: B-cell lymphomas [internet publication].Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • MALT lymphoma images
  • Diferenciales

    • Mantle cell lymphoma
    • Chronic lymphocytic leukemia/small lymphocytic lymphoma
    • Follicular lymphoma
    Más Diferenciales
  • Guías de práctica clínica

    • NCCN clinical practice guidelines in oncology: B-cell lymphomas
    • Guideline for the diagnosis and management of marginal zone lymphomas
    Más Guías de práctica clínica
  • Folletos para el paciente

    Non-Hodgkin lymphoma

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad